Open AccessNew risk prediction models in England may lead to targeted PCSK9 inhibitor treatment, for patients with established cardiovascular disease
European Journal Of Preventive CardiologyPeer ReviewedTaavi Tillmann2020Journals
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support